Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Tiffany Boughtwood.jpg

Tiffany Boughtwood (BSc MBA) is the Program Manager of Australian Genomics, responsible for the executive operations of this collaborative research network across Australia. 

Tiffany has over 20 years’ experience in molecular biology and research management.   She has led accredited genomic sequencing facilities, operated academic and accredited diagnostic laboratories, engaged in research in neurodegenerative diseases and cancer, and consulted in genomic implementation and project management.

Over the past three years with Australian Genomics, Tiffany has managed a distributed network of staff to support the coordination, delivery and process evaluation of this large $55M program of work.  In this time, the Australian Genomics collaboration has tripled in size to over 80 partner institutions, and over 400 investigators and collaborators. It enrols participants across every Australian state and territory through 32 hospitals, into clinical flagship projects in rare diseases, cancers and reproductive carrier screening. 25,000 Australians will be enrolled and offered genomic healthcare through Australian Genomics-led programs by 2022.

Tiffany is a passionate proponent of the potential of genomics in healthcare, and is dedicated to the delivery of the Australian Genomics vision both locally, and internationally.

Australian Genomics Health Alliance: https://www.australiangenomics.org.au

Publications :

  1. 1.       Hansen, D, Dinger M, Hofmann, O, Thorne, N, Boughtwood, T. 2019, ‘Preparing Australia for genomic medicine: data, computing and digital health’ Medical Journal of Australia, 210(6), doi: 10.5694/mja2.50032
  2. 2.       Long, JC, Pomare, C, Best, S, Boughtwood, T, North, K, Ellis, LA, Churruca, K & Braithwaite, J 2019, 'Building a learning community of Australian clinical genomics: a social network study of the Australian Genomic Health Alliance', BMC Medicine, vol. 17, no. 1, doi:10.1186/s12916-019-1274-0
  3. 3.       Stark, Z, Dolman, L, Manolio, TA, Ozenberger, B, Hill, SL, Caulfied, MJ, Levy, Y, Glazer, D, Wilson, J, Lawler, M, Boughtwood, T, Braithwaite, J, Goodhand, P, Birney, E & North, KN 2019, 'Integrating Genomics into Healthcare: A Global Responsibility', The American Journal of Human Genetics, vol. 104, no. 1, pp. 13-20, doi:10.1016/j.ajhg.2018.11.014
  4. 4.       Dyke, SOM, Linden, M, Lappalainen, I, Argila, JRD, Carey, K, Lloyd, D, Spalding, JD, Cabili, MN, Kerry, G, Foreman, J, Cutts, T, Shabani, M, Rodriguez, LL, Haeussler, M, Walsh, B, Jiang, X, Wang, S, Perrett, D, Boughtwood, T, et al, P 2018, 'Registered access: authorizing data access', European Journal of Human Genetics, vol. 26, no. 12, pp. 1721--1731, doi:10.1038/s41431-018-0219-y
  5. 5.       Haas, M, Boughtwood, T, Quinn, M; ‘The ethics approval process for multi-site research studies in Australia: changes sought by the Australian Genomics initiative’ Medical Journal Australia 2019 (in press)
  6. Brodtmann, A, Werden, E, Pardoe, H, Li, Q, Jackson, G, Donnan, G, Cowie, T, Bradshaw, J, Darby, D & Cumming, T 2014, 'Charting Cognitive and Volumetric Trajectories after Stroke: Protocol for the Cognition and Neocortical Volume after Stroke CANVAS Study', International Journal of Stroke, vol. 9, no. 6, pp. 824--828, doi:10.1111/ijs.12301
  7. Scarr, E, Um, JY, Cowie, TF & Dean, B 2013, 'Cholinergic muscarinic M4 receptor gene polymorphisms: A potential risk factor and pharmacogenomic marker for schizophrenia', Schizophrenia Research, vol. 146, no. 1-3, pp. 279--284, doi:10.1016/j.schres.2013.01.023
  8. Wilkins, EJ, Rubio, JP, Kotschet, KE, Cowie, TF, Boon, WC, O'Hely, M, Burfoot, R, Wang, W, Sue, CM, Speed, TP, Stankovitch, J & Horne, MK 2012, 'A DNA resequencing array for genes involved in Parkinson's disease', Parkinsonism & Related Disorders, vol. 18, no. 4, pp. 386-- 390, doi:10.1016/j.parkreldis.2011.12.012
  9. Scarr, E, Cowie, TF, Kanellakis, S, Sundram, S, Pantelis, C & Dean, B 2008, 'Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia', Molecular Psychiatry, vol. 14, no. 11, pp. 1017-1023, doi:10.1038/mp.2008.28
  10. Birmingham, N, Cowie, T, Paine, M, Storey, E & McLean, C Dec , 'Frontotemporal dementia and Parkinsonism linked to chromosome 17 in a young Australian patient with the G389R Tau mutation.', Neuropathol Appl Neurobiol, vol. 3, no. 34, pp. 366 - 370
  11. Rowe, C, Ng, S, Ackerman, U, Gong, S, Pike, K, Savage, G, Cowie, T, Dickinson, K, Maruff, P, Darby, D, Smith, S, Woodward, M, Tochon-Danguy, H, O'Keefe, G, Klunk, W, Mathis, C, Price, J, Masters, C & Villemagne, V 15 M, 'Imaging beta-amyloid burden in aging and dementia.', Neurology, vol. 20, no. 68, pp. 1718 - 1725